{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:40:28Z","timestamp":1697434828063},"reference-count":89,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T00:00:00Z","timestamp":1175731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Bipolar disorder (BPD) is a severe and chronic illness, with a lifetime prevalence of approximately 1.5%. Despite the availability of some mood stabilizing drugs including lithium, valproate (valproic acid), lamotrigine and carbamazepine, BPD is characterized by high rates of recurrence, as treatment with these and other drugs is ineffective for and not well\u2010tolerated by a significant percentage of patients. Most drugs currently used for the maintenance treatment of BPD are anticonvulsants (e.g., valproate, carbamazepine and lamotrigine).<\/jats:p><jats:p><jats:bold>Objectives:\u2002<\/jats:bold> The aim of this paper is to review the studies characterizing the anticonvulsant efficacy of valproate\u2010like carboxylic acids and related compounds, some of which may have potential for the treatment of manic\u2010depressive illness.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The data reviewed herein demonstrate clearly that some dietary fatty acids and other valproate\u2010like carboxylic acids exhibit potent anticonvulsant activity, and may thus be candidates for mood stabilizing treatment options for BPD.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2007.00351.x","type":"journal-article","created":{"date-parts":[[2007,4,6]],"date-time":"2007-04-06T00:47:01Z","timestamp":1175820421000},"page":"197-205","source":"Crossref","is-referenced-by-count":1,"title":["Anticonvulsant efficacy of valproate\u2010like carboxylic acids: a potential target for anti\u2010bipolar therapy"],"prefix":"10.1111","volume":"9","author":[{"given":"Abed N","family":"Azab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam L","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,5]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.2.115"},{"key":"e_1_2_5_3_2","volume-title":"The Global Burden of Disease","author":"Murray CJL","year":"1996"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035354"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0506"},{"key":"e_1_2_5_6_2","first-page":"21","article-title":"Making optimal use of combination pharmacotherapy in bipolar disorder","volume":"65","author":"Bowden CL","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2060587"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/341197a0"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/306067a0"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2230237"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/35073015"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.56.070187.001111"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)70391-3"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(74)90022-8"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)68256-0"},{"key":"e_1_2_5_16_2","first-page":"1","volume-title":"Bipolar Medications: Mechanism of Action","author":"Attack JR","year":"2000"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1176\/ajp.156.12.1902","article-title":"Temporal dissociation between lithium\u2010induced changes in frontal lobe myo\u2010inositol and clinical response in manic\u2010depressive illness","volume":"156","author":"Moore GJ","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.420"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.16.8455"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.13.5766"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(03)00206-2"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001518"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0103"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.01.008"},{"key":"e_1_2_5_25_2","first-page":"1","article-title":"AR\u2010A014418, a selective GSK\u20103 inhibitor, produces antidepressant\u2010like effects in the forced swim test","volume":"26","author":"Gould TD","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00165-1"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0721327.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1999.720879.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004179200"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/417292a"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312078200"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1016\/S0021-9258(19)70191-4","article-title":"Stereochemistry of the myo\u2010inositol\u20101\u2010phosphate synthase reaction","volume":"255","author":"Loewus MW","year":"1980","journal-title":"J Biol Chem"},{"key":"e_1_2_5_33_2","first-page":"868","article-title":"Valproate decreases inositol biosynthesis","volume":"56","author":"Shaltiel G","year":"2004","journal-title":"Mol Psychiatry"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex versus lithium and placebo in the treatment of mania","volume":"271","author":"Bowden CL","year":"1994","journal-title":"JAMA"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431111"},{"key":"e_1_2_5_37_2","first-page":"263","volume-title":"Mania: Clinical and Research Perspectives","author":"Ketter TA","year":"1998"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0906"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.3.463"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-5618.2003.00070.x"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0402"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(83)90134-X"},{"key":"e_1_2_5_43_2","first-page":"335","volume-title":"Dietary Reference Intakes for Energy, Carbohydrates, Fibre, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids (Macronutrients)","author":"National Academic Press","year":"2002"},{"key":"e_1_2_5_44_2","volume-title":"USDA Data Tables for Individual Fatty Acids Intakes. Results from the 1995 Continuing Survey of Food Intakes by Individuals","author":"Chug Ahuja JK","year":"1998"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216100-00004"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02939.x"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(82)90010-7"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016055517724"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.25801.x"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00100-8"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1984.tb05637.x"},{"key":"e_1_2_5_52_2","first-page":"933","volume-title":"Goodman and Gilman's Pharmacological Basis of Therapeutics","author":"Roden DM","year":"2001"},{"key":"e_1_2_5_53_2","first-page":"521","volume-title":"Goodman and Gilman's Pharmacological Basis of Therapeutics","author":"McNamara JQ","year":"2001"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.9.3997"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02562284"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.8.4182"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021365"},{"key":"e_1_2_5_58_2","first-page":"779","article-title":"Multiple actions of phenytoin on mouse spinal cord neurons in cell culture","volume":"227","author":"Mclean MJ","year":"1983","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"e_1_2_5_59_2","first-page":"1001","article-title":"Sodium valproate, but not ethosuxmide, produces use and voltage\u2010dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture","volume":"237","author":"Mclean MJ","year":"1986","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01467-2"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90387-5"},{"key":"e_1_2_5_62_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-2275(20)40751-5","article-title":"Effect of a high linoleate and a high alpha\u2010linoleate diet on general behaviour and drug sensitivity in mice","volume":"34","author":"Nakashima Y","year":"1993","journal-title":"J Lipid Res"},{"key":"e_1_2_5_63_2","volume-title":"Fish and Human Health","author":"Lands WEM","year":"1986"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-999-0457-6"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(05)80180-0"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.11.1433"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(99)00070-4"},{"key":"e_1_2_5_68_2","first-page":"1037","article-title":"Fasting as a method for treating epilepsy","volume":"99","author":"Geyelin HR","year":"1921","journal-title":"Med Res"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1974.tb04943.x"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02066.x"},{"key":"e_1_2_5_71_2","first-page":"231","article-title":"Anticonvulsant properties of the ketogenic diet in mice","volume":"180","author":"Uhlemann ER","year":"1972","journal-title":"J Pharmacol Exp Therapeutic"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.6.1358"},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.08901.x"},{"key":"e_1_2_5_74_2","volume-title":"Manic Depressive Illness","author":"Goodwin FK","year":"1990"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.11.1635"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.5.407"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63062361.x"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00243-7"},{"key":"e_1_2_5_79_2","doi-asserted-by":"publisher","DOI":"10.3109\/10673229609030527"},{"key":"e_1_2_5_80_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116245"},{"key":"e_1_2_5_81_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006875010120"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90656-6"},{"key":"e_1_2_5_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-198611000-00032"},{"key":"e_1_2_5_84_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1991.tb01303.x"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00017a024"},{"key":"e_1_2_5_86_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx950216s"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200304000-00014"},{"key":"e_1_2_5_88_2","first-page":"114","article-title":"Single\u2010dose tolerance and pharmacokinetics of 2\u2010n\u2010propyl\u2010delta\u20102\u2010(E) \u2010pentanoate (delta\u20102 (E) valproate) in healthy male volunteers","volume":"20","author":"Dusing RH","year":"1992","journal-title":"Pharmaceutisch Weekblad Scientific Edition"},{"key":"e_1_2_5_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01962705"},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01369.x"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2007.00351.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2007.00351.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:23:32Z","timestamp":1697412212000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2007.00351.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,5]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1399-5618.2007.00351.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2007.00351.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,5]]}}}